Legacy Project - Diversity Supplement

NIH RePORTER · NIH · R01 · $243,532 · view on reporter.nih.gov ↗

Abstract

Project Summary: Legacy – what one leaves behind and how one hopes to be remembered after death— is an important part of the human experience. In the parent grant, our related preliminary work, we have encountered multiple anecdotal reports from people considering their legacy as they make cancer treatment choices, suggesting that legacy has a clear financial component and is relevant to understanding cancer-related financial hardship. However, very limited research exists about legacy planning as it relates to cancer care. Deeper understanding of the legacy construct and how it relates to cancer-related financial hardship and treatment choices could guide how to incorporate legacy considerations into financial navigation interventions like the one in the parent grant. This supplemental study will examine how people with cancer consider legacy, both in general and when making medical decisions, with focus on the financial aspects of legacy. Through a critical literature review and semi-structured interviews with cancer patients and their families, this study will build a conceptual model and preliminary data that will inform a future R01-level (or equivalent) research grant proposal led by Dr. Marlaine Figueroa Gray, junior faculty member, first generation college graduate, and member of an underrepresented minority group, at Kaiser Permanente Washington Health Research Institute.

Key facts

NIH application ID
10377837
Project number
3R01CA237322-03S2
Recipient
KAISER FOUNDATION RESEARCH INSTITUTE
Principal Investigator
Matthew P Banegas
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$243,532
Award type
3
Project period
2019-09-01 → 2024-08-31